Derek H Jones
Overview
Explore the profile of Derek H Jones including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
351
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Minokadeh A, Matarasso S, Jones D
Dermatol Surg
. 2024 Aug;
50(9S):S70-S72.
PMID: 39196837
Background And Objective: Botulinum toxin treatment is gaining popularity among men for cosmetic purposes driven by workplace competition and a desire for confidence and youthfulness. Because of the unique features...
2.
Biesman B, Green J, George R, Jacob C, Palm M, Jones D, et al.
Aesthet Surg J
. 2024 Apr;
44(9):1001-1013.
PMID: 38573527
Background: Hyaluronic acid injections are increasingly administered for correction of infraorbital hollows (IOHs). Objectives: The objective of this study was to examine the effectiveness (IOH correction) and safety of Restylane...
3.
Ogilvie P, Jones D, Avelar R, Jonker A, Monroe R, Carruthers J
Dermatol Surg
. 2022 May;
48(6):664-669.
PMID: 35616616
Background: The use of esthetic products by millennials is increasing, yet published clinical trial data in this population are limited. Objective: To compare the efficacy and safety of prabotulinumtoxinA for...
4.
Kaufman-Janette J, Avelar R, Biesman B, Draelos Z, Gross J, Jones D, et al.
Aesthet Surg J
. 2021 Jul;
41(12):1494.
PMID: 34309676
No abstract available.
5.
Kaufman-Janette J, Avelar R, Biesman B, Draelos Z, Gross J, Jones D, et al.
Aesthet Surg J
. 2021 May;
41(12):1409-1422.
PMID: 33944905
Background: PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum. Objectives: The authors sought to investigate the safety of prabotulinumtoxinA for treatment of glabellar lines. Methods: This...
6.
Kakar R, Minokadeh A, Jones D
Dermatol Surg
. 2021 Feb;
47(7):1030-1031.
PMID: 33577213
No abstract available.
7.
Jones D, Fitzgerald R, Cox S, Butterwick K, Murad M, Humphrey S, et al.
Dermatol Surg
. 2021 Feb;
47(2):214-226.
PMID: 33543879
No abstract available.
8.
Alam M, Kakar R, Dover J, Harikumar V, Kang B, Wan H, et al.
JAMA Dermatol
. 2020 Dec;
157(2):174-180.
PMID: 33377939
Importance: Soft-tissue augmentation with skin fillers can be delivered with needles or microcannulas, but unwanted vascular occlusions are possible. Objective: To determine whether filler-associated vascular occlusion events of the face...
9.
10.
Humphrey S, Jones D, Carruthers J, Carruthers A, Beleznay K, Wesley N, et al.
J Am Acad Dermatol
. 2020 Feb;
83(1):86-95.
PMID: 32035107
Background: Recent publications have suggested an increased risk of delayed adverse events (DAEs) with a smooth, cohesive 20-mg/mL hyaluronic acid filler, Juvéderm Voluma (HA-V). Objective: To examine the occurrence of...